Medium materiality6/10
Jazz Pharmaceuticals price target raised to $299 from $277 at RBC Capital
Why it may matterVerify against the original reporting
Bullish upgrade
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Target $299; current price $247.45; RBC Capital; priceChangeSinceSignal -0.16.
- RBC Capital raises Jazz target to $299; price $247.45.
Key facts
- 01
Target: $299
- 02
Posted price: $247.45
- 03
Analyst firm: RBC Capital
- 04
Analyst: Leonid Timashev
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.